How to Use AI for an OB/GYN Practice in 2026: ACOG/SMFM, HIPAA Reproductive Health 2024, MIPS MVP, and the Owner Scorecard
Published June 7, 2026 · 14 min read
The 7-Layer AI Stack for Modern OB/GYN Practices
| Layer | Purpose | Tools |
|---|---|---|
| Intake | Pre-visit + screening + RFV | Phreesia + NexHealth + Klara + Luma + Relatient |
| Ambient SOAP | OB/GYN E/M + global OB + procedure | DAX Copilot + DeepScribe + Abridge + Suki + Heidi + Freed + Sunoh.ai |
| EHR + ACOG | Bulletin + Committee Opinion alignment | Epic + athena + eCW + NextGen + Modernizing + Greenway + ACOG eBulletin |
| OB US + AI | Biometry + anomaly + AFI | GE Voluson SonoCNS + Samsung HERA + Philips EPIQ + Mindray + Canon |
| Prior-Auth | Endometrial ablation + LARC + biologic | CoverMyMeds + Glidian + Surescripts + Office Ally + Availity + Waystar + Cohere |
| Compliance | HIPAA + Reproductive Health Final Rule | Drata + Vanta + Compliancy + MedTrainer + HIPAA One + Keragon |
| Outcomes | Recall + reviews + scorecard | Weave + Phreesia + BirdEye + Podium + NiceJob + Swell |
10 Copy-Paste Prompts for OB/GYN Practices
- New OB intake synthesis — Summarize HPI + OB hx (G/P, prior CD, GDM, PEC), GYN hx, sexual + contraception hx, family hx (BRCA + Lynch), social + travel for Zika/CMV. Output ACOG-aligned problem list, screening gaps (USPSTF + ACS + ACOG), red-flag review (PEC, PTB risk, ectopic, OHSS).
- Ambient OB/GYN SOAP — Generate OB SOAP with CPT 99202-99215 + 59400/59510/59610 global + 58150-58294 hyst + 57452-57461 colpo/LEEP + 58661/58662 lap + 76801-76817 OB US + 76830 TV + 81025 + 87624 + 88141-88175 cytology + ICD-10 N80-N98 + O00-O9A + Z34. Cite ACOG Practice Bulletin number with citation-verify gate.
- USPSTF + ACS preventive-screening reminder — Build patient-specific reminders for cervical cancer (USPSTF 21-29 cytology q3y, 30-65 hrHPV q5y, ACS 2020 25+ primary HPV q5y), breast (USPSTF 40-74 q2y per 2024 update, ACS 45-54 annual), colon (USPSTF 45-75), bone density (USPSTF 65+), GT for BRCA (USPSTF 2019).
- HIPAA Reproductive Health 2024 attestation — Draft attestation form + workflow for reproductive-care PHI requests per 45 CFR 164.509 (Apr 22 2024 Final Rule, compliance Dec 23 2024). Update NPP by Feb 16 2026. Train minimum-necessary logging.
- Prior-auth + denial appeal — Build PA + appeal for endometrial ablation NovaSure/Minerva (ACOG PB 81/136), LARC Mirena/Skyla/Liletta/Kyleena/Paragard/Nexplanon, dyspareunia biologic, HRT, Addyi/Vyleesi (ACOG PB 213/Female Sexual Dysfunction), ulipristal/elagolix (ACOG PB 228 Endometriosis), per Cohere/Evicore + payer LCD.
- OB US AI pre-read — Pre-read 1st-trimester dating + NT (FMF + ISUOG), 2nd-trimester anatomic survey (AIUM/ACOG/SMFM), AFI/SDP, BPP, growth scan, Doppler MCA + UA + DV. Output structured report with red-flags (placenta previa, vasa previa, accreta, IUGR less than 10th, oligo/poly).
- Postpartum + depression screen — Generate postpartum visit plan per ACOG Committee Opinion 736 + SMFM (4-6 wk comprehensive), EPDS + PHQ-9 depression screen, breastfeeding, contraception transition, GDM-to-T2D follow-up (75g GTT 4-12 wk), HTN/PEC follow-up (BP cuff at home program).
- State-compliant AI-scribe consent — Draft consent flow per CA AB 3030 + TX SB 815 + UT HB 452 + IL HB 1806 + FSMB Model Policy on AI 2024. Distinguish ambient AI listening vs. patient-facing AI vs. autonomous decision support, with opt-out preserved.
- MIPS MVP Promoting Wellness in Women's Health — Build dashboard for cervical (Q309), breast (Q112), prenatal (Q335/336), postpartum + depression (Q418), chlamydia (Q310), with Improvement Activity IA_PM_22 + Promoting Interoperability e-Rx + HIE.
- Owner monthly scorecard — Track new OB starts/MD-month, well-woman/MD-week, procedure mix (colpo/LEEP/lap/hyst/ablation), GYN no-show, denial rate, MIPS MVP measure performance, BSI/SSI/CAUTI, online review velocity, state-compliant ad audit.
The 12-Item OB/GYN Compliance Floor
- HIPAA Privacy + Security + Breach Notification 45 CFR 160 + 164 + BAA with every AI vendor
- HIPAA Reproductive Health 2024 Final Rule (Apr 22 2024 / compliance Dec 23 2024) attestation + NPP update by Feb 16 2026
- ACOG Practice Bulletins + Committee Opinions + SMFM Consult Series citation-verify gate (no AI auto-finalize)
- USPSTF + ACS + ACOG preventive-screening matrix per 2024-2025 updates
- State AI-scribe consent (CA AB 3030 + TX SB 815 + UT HB 452 + IL HB 1806) + FSMB Model Policy on AI 2024
- AKS 42 USC §1320a-7b + Stark §1395nn + Sunshine $13.46/$134.49 FY 2026 on device + drug rep + IUD/LARC
- MIPS MVP Promoting Wellness in Women's Health 2025 + quality + IA + PI
- EMTALA + 42 CFR 489.24 + post-Dobbs OB emergency policy + state-by-state legal review
- FDA-cleared AI-SaMD only (510(k) or De Novo) for clinical decision support; document version + reverify quarterly
- OSHA Bloodborne Pathogens 29 CFR 1910.1030 + needlestick + sharps safety + exposure plan
- CLIA waived/moderate complexity for in-office UPT + UA + wet mount + KOH + STI rapid + CLIA cert tracking
- FTC Endorsement Guides 2023 + Fake Reviews Rule 16 CFR 465 $51,744/violation FY 2026 + state UDAP
60-Day Rollout Plan
Days 1-15: BAA inventory + HIPAA Reproductive Health attestation form + NPP update + AI-scribe pilot one MD; build USPSTF + ACS preventive-screening recall list.
Days 16-30: Roll ambient scribe to all clinicians; deploy OB US AI pre-read on Voluson/HERA/EPIQ; baseline MIPS MVP measures.
Days 31-45: Prior-auth automation (LARC + ablation + endometriosis biologic); patient-side recall via Weave/Phreesia for Pap + mammo + bone density.
Days 46-60: Owner scorecard live; state-compliant ad audit; quarterly AI-SaMD reverify; FY 2026 Sunshine reconciliation.
8 Mistakes That Kill OB/GYN AI Rollouts
- Letting AI auto-finalize an OB SOAP without MD/PA/NP review and ACOG citation-verify
- Missing the HIPAA Reproductive Health 2024 attestation requirement on records release
- Failing to update Notice of Privacy Practices by Feb 16 2026
- Using a non-FDA-cleared AI-SaMD for clinical decision support and citing it as authoritative
- Ignoring state AI-scribe consent statutes (CA + TX + UT + IL) and FSMB Model Policy on AI 2024
- Skipping post-Dobbs state legal review on OB emergency + miscarriage management workflows
- Treating ambient scribe vendor dashboards as truth instead of validating against EHR + claims
- Forgetting Sunshine reporting on device + drug rep meals + samples + LARC training honoraria
Frequently Asked Questions
What is the single biggest 2026 AI risk for an OB/GYN practice?
Two tied: (1) HIPAA Reproductive Health 2024 Final Rule (Apr 22 2024 / compliance Dec 23 2024) — any AI vendor that touches PHI tied to reproductive care must support the new attestation requirement before disclosing PHI for non-healthcare purposes, and your BAA + minimum-necessary logs must reflect this; and (2) ACOG/SMFM Practice Bulletin alignment — AI-generated clinical recommendations must be pre-approved against current ACOG Practice Bulletins, Committee Opinions, and SMFM Consult Series with citation-verify gate per FSMB Model Policy on AI 2024.
Can ambient AI scribes document E/M, OB visits, and procedures correctly?
Yes — DAX Copilot, DeepScribe, Abridge, Suki, Heidi, Freed, Sunoh.ai support ambient scribe for OB/GYN with CPT 99202-99215 office E/M, CPT 59400/59510/59610 global OB, CPT 58150-58294 hysterectomy, CPT 57452-57461 colpo + LEEP, CPT 58661/58662 laparoscopy, CPT 76801-76817 OB ultrasound, CPT 76830 transvaginal, CPT 81025 urine pregnancy, CPT 87624 HPV, CPT 88141-88175 cytology + Pap, ICD-10 N80-N98 + O00-O9A + Z34. Output requires MD/PA/NP review + sign-off; never auto-finalize.
How does the HIPAA Reproductive Health 2024 Final Rule change my workflow?
Effective Apr 22 2024 / compliance Dec 23 2024. Three changes: (1) prohibit use/disclosure of PHI to investigate or impose liability on patients, providers, or those facilitating reproductive care lawful in the state where it occurred; (2) require attestation that PHI requested for law-enforcement or non-healthcare purposes is NOT for prohibited reproductive-care investigation; (3) update Notice of Privacy Practices by Feb 16 2026. AI vendor BAAs must reflect attestation handling + minimum-necessary review on records release.
What MIPS measures and MVP should an OB/GYN practice prioritize?
2025 MIPS MVP Promoting Wellness in Women's Health is the canonical track. Quality measures: cervical cancer screening (Q309/USPSTF + ACS 2020), breast cancer screening (Q112/USPSTF), prenatal care (Q335/Q336), postpartum follow-up + depression screening (Q418), chlamydia screening (Q310). Improvement Activities: AI-assisted preventive screening reminders (IA_PM_22), patient-reported outcomes. Promoting Interoperability: e-prescribing controls + HIE bidirectional exchange.
What is realistic ROI in 90 days?
Conservative targets: ambient scribe → 1.5-2.5 hrs/day saved per clinician + 15-25 percent more visits per session; AI prior-auth + denial appeal → 12-22 percent denial-rate reduction; preventive-screening reminders → 8-15 percent lift on Pap, mammo, GT. Validated against EHR + claims data, not vendor dashboards.
Authoritative Sources
- ACOG Practice Bulletins + Committee Opinions + SMFM Consult Series (current editions)
- HIPAA Reproductive Health 2024 Final Rule (Apr 22 2024 / compliance Dec 23 2024)
- USPSTF Recommendations + American Cancer Society 2020 Cervical + 2024 Breast updates
- CMS MIPS MVP Promoting Wellness in Women's Health 2025
- FSMB Model Policy on AI 2024 + state AI-scribe statutes
- FDA AI-SaMD 510(k) and De Novo clearances
- EMTALA 42 USC §1395dd + 42 CFR 489.24 + post-Dobbs state legal review